. Author manuscript; available in PMC: 2018 Oct 1.

Published in final edited form as: Acad Radiol. 2017 May 19;24(10):1240–1255. doi: 10.1016/j.acra.2017.03.020

Table 3.

Summary of the means and standard errors of relative changes in [Hb], [HbO₂], [HbT], and SO₂ at the tumor region of interest from baseline over 5 binned time windows for each response category. Beneath the response category, the number of patients in each group (n) is also provided.

		Response to therapy at the tumor ROI (% change from baseline)
Group	Percent therapy complete	[Hb]	[HbO₂]	[HbT]	SO₂
Responders (n = 6)	10 (0, 20]	−2 ± 8	−6 ± 7	−5 ± 7	−2 ± 1
	30 (20, 40]	−13 ± 7	−36 ± 6	−28 ± 6	−12 ± 3
	50 (40, 60]	−4 ± 5	−52 ± 5	−35 ± 4	−27 ± 4
	70 (60, 80]	−4 ± 6	−56 ± 5	−38 ± 4	−32 ± 4
	90 (80, 100]	4 ± 7	−52 ± 4	−36 ± 4	−26 ± 4
Non-responders (n = 2)	10 (0, 20]	−9 ± 7	−9 ± 7	−9 ± 7	0 ± 1
	30 (20, 40]	1 ± 4	−5 ± 4	−3 ± 4	−2 ± 0
	50 (40, 60]	1 ± 5	−3 ± 1	−2 ± 2	−1 ± 1
	70 (60, 80]	0 ± 11	−15 ± 12	−10 ± 12	−6 ± 2
	90 (80, 100]	23 ± 12	3 ± 15	10 ± 14	−8 ± 3